Dr. Corey D. Kershaw, MD

Dr. Kershaw practices at William P. Clements Jr. University Hospital in Dallas, Texas, part of The University of Texas System.

Dr. Kershaw's NPI, 1811939325, was assigned on June 11, 2006. Dr. Kershaw graduated from McGovern Medical School in 2000. Dr. Kershaw's Texas license number on file is N5153.

Dr. Kershaw's primary practice is William P. Clements Jr. University Hospital, at 6201 Harry Hines Blvd, Dallas, TX 75390 in Dallas County. The practice phone is (214) 633-5555.

Dr. Kershaw's primary practice is William P. Clements Jr. University Hospital in Dallas, Texas, part of The University of Texas System. Dr. Kershaw is also affiliated with Parkland Memorial Hospital. The medical group on file is University of Texas Southwestern Medical Center. Dmand AI also links Dr. Kershaw to 1 more hospital and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kershaw practices, 4 sites in all. Vendor and product names are available with a free account.

Pulmonary disease is Dr. Kershaw's primary specialty in the NPI Registry, under taxonomy code 207RP1001X. Dr. Kershaw is board certified in critical care medicine by the American Board of Internal Medicine. Dmand AI has Dr. Kershaw's licenses on file in 2 states: Texas and Georgia.

Dmand AI lists asthma, chronic lung disease, chronic obstructive pulmonary disease (COPD), pneumonia and pulmonary fibrosis among the conditions Dr. Kershaw treats.

CMS data shows 1,051 Medicare services from Dr. Kershaw across 12 procedure codes in 2024, for 506 Medicare patients. Medicare paid $48,509 for them.

CMS counts 506 Medicare patients who saw Dr. Kershaw in 2024. The largest group is 65 to 74, with 217 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 9% are also on Medicaid. Their average risk score is 2.38, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Kershaw's median patient age at 65, with 55% women.

In 2024, Dr. Kershaw wrote 466 Medicare Part D claims for 84 patients. 66% of them were for generic drugs. CMS names the drug for 325 of them, across 11 drugs with 11 or more claims each, at $565,617 in total drug cost. In 2023, CMS named 397 claims across 14 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 83 out of 100 for Dr. Kershaw for performance year 2024, reported as part of a group. Dr. Kershaw accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Kershaw as offering telehealth.

Dmand AI links 27 papers to Dr. Kershaw, published from 2008 to 2025. 2021 was the busiest year, with 7. The most frequent topics are COVID-19, Lung Transplantation and SARS-CoV-2. Dr. Kershaw has published most often in Alcohol Clin Exp Res. Dr. Kershaw's most frequent co-authors are Lance S. Terada, MD, Amit Banga, MD and Srinivas Bollineni, MD.

Dmand AI links Dr. Kershaw to 1 clinical trial. Conditions studied include Idiopathic Pulmonary Fibrosis and Pulmonary Fibrosis.

CMS Open Payments shows 201 general payments to Dr. Kershaw from 6 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 65% of the total. Boehringer Ingelheim Pharmaceuticals, Inc. paid the most, $153,471.

Dmand AI lists 1 award for Dr. Kershaw, most recently CMS Stage 1 EHR in 2012.

Dr. Kershaw graduated from McGovern Medical School in 2000.

Dr. Kershaw is in network with 21 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. HMO plans come from the most carriers, 13. Check the plan with the practice before a visit.